Microvascular dysfunction in women with polycystic ovary syndrome

Human Reproduction

Volumn 20, Issue 11, 2005, Pages 3219-3224

  Lakhani, K ^a   Leonard, A ^b   Seifalian, A M ^c   Hardiman, P ^b,c  

^a NORTH MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Acetylcholine; Endothelium; Erythrocyte flux; Microcirculation; Polycystic ovary syndrome

Indexed keywords

ACETYLCHOLINE; INSULIN; NITROPRUSSIDE SODIUM; TESTOSTERONE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOREARM BLOOD FLOW; HUMAN; INSULIN BLOOD LEVEL; IONTOPHORESIS; LASER DOPPLER FLOWMETRY; MICROANGIOPATHY; MICROVASCULARIZATION; OVARY POLYCYSTIC DISEASE; SKIN BLOOD FLOW; TESTOSTERONE BLOOD LEVEL; VASODILATATION;

EID: 27944473677     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dei199     Document Type: Article

References (37)

1. Adams MR, Williams JK and Kaplan JR (1995) Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness. Arterioscler Thromb Vasc Biol 15,562-570.
2. Berghoff M, Kathpal M, Kilo S, Hilz M and Freeman R (2002) Vascular and neural mechanisms of ACh-mediated vasodilation in the forearm cutaneous microcirculation. J Appl Physiol 92,780-788.
3. Bucala R, Tracey KJ and Cerami A (1991) Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 87,432-438.
4. Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park JY, King GL, LoGerfo FW, Horton ES and Veves A (1999) Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 48,1856-1862.
5. Caselli A, Rich J, Hanane T, Uccioli L and Veves A (2003) Role of C-nociceptive fibres in the nerve axon reflex-related vasodilation in diabetes. Neurology 60,297-300.
6. Conway GS, Honour JW and Jacobs HS (1989) Heterogeneity of the polycystic ovary syndrome: Clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol (Oxf) 30,459-470.
7. Conway GS, Agrawal R, Betteridge DJ and Jacobs HS (1992) Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol (Oxf) 37,119-125.
8. Dahlgren E, Janson PO, Johansson S, Lapidus L and Oden A (1992) Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand 71,599-604.
9. Dunaif A and Thomas A (2001) Current concepts in the polycystic ovary syndrome. Ann Rev Med; 52,401-419.
10. Dunaif A, Graf M, Mandeli J, Laumas V and Dobrjansky A (1987) Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab 65,499-507.
11. Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A and Licholai T (1992) Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 41,1257-1266.
12. Ferriman DM and Gallwey JD (1961) Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21,144-147.
13. Fox R (1999) Transvaginal ultrasound appearances of the ovary in normal women and hirsute women with oligomenorrhoea. Aust NZ J Obstet Gynaecol 39,63-68.
14. Franks S (1989) Polycystic ovary syndrome: A changing perspective. Clin Endocrinol (Oxf); 31,87-120.
15. Guzick DS, Talbott EO, Sutton-Tyrrell K, Herzog HC, Kuller LH and Wolfson SK, Jr (1996) Carotid atherosclerosis in women with polycystic ovary syndrome: Initial results from a case-control study. Am J Obstet Gynecol 174,1224-1229.
16. Herman SM, Robinson TJ, McCredie RJ, Adams MR and Boyer MJ (1997) Androgen deprivation is associated with enhanced endothelium-dependent dilation in adult men. Arterioscler Thromb Vasc Biol 17,2004-2009.
17. Hutchinson SJ, Sudhir K, Chou TM, Sievers RE, Zhu BQ, Sun YP, Deedwania PC, Glantz SA, Parmley WW and Chatterjee K (1997) Testosterone worsens endothelial dysfuction associated with hypercholesterolemia and environmental tobacco smoke exposure in male rabbit aorta. J Am Coll Cardiol 29,800-807.
18. Khan F, Litchfield SJ, Stonebridge PA and Belch JJ (1999) Lipid-lowering and skin vascular responses in patiens with hypercholesterolaemia and peripheral arterial obstructive disease. Vasc Med 33,805-812.
19. Lakhani K, Seifalian AM and Hardiman P (2002) Impaired carotid viscoelastic properties in women with polycystic ovaries. Circulation 106,81-85.
20. Lakhani K, Hardiman P and Seifalian AM (2004) Intima-media thickness of elastic and muscular arteries of young women with polycystic ovaries. Atherosclerosis 175,353-359.
21. Morris SJ and Shore AC (1996) Skin blood flow responses to the intophoresis of acetylcholine and sodium nitroprusside in man: Possible mechanism. J Physiol 496,531-542.
22. Morris SJ, Shore AC and Tooke JE (1995) Response of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM. Diabetologia 38,1337-1344.
23. Okon EB, Szado T, Lajer I, McManus BM and Van Breeman C (2003) Augmented contractile response of vascular smooth muscle in a diabetic mouse model. J Vasc Res 40,520-530.
24. Panza JA, Casin PR, Kilcoyne CM and Quyyumi AA (1994) Impaired endothelium-dependent vasodilation in patients with essential hypertension: Evidence that the abnormality is not at the muscarinic receptor level. J Am Coll Cardiol 23,1610-1616.
25. Paradisi G, Steinberg HO, Hempfling A, Cronin J, Hook G, Shepard MK and Baron A (2001) Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 103,1410-1415.
26. Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH and Jacobs HS (1998) Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol 51,581-586.
27. Pitie D, Watkins PJ and Edmonds ME (1997) NO-dependent smooth muscle vasodilatation is reduced in NIDDM patients with peripheral sensory neuropathy. Diabet Med 14,284-290.
28. Robinson S, Kiddy D, Gelding SV, Willis D, Niththyananthan R, Bush A, Johnston DG and Franks S (1993) The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin Endocrinol (Oxf) 39,351-355.
29. Rodriguez-Manas L, Arribas S, Giron C, Villamor J, Sanchez-Ferrer CF and Marin J (1993) Interference of glycosylated human hemoglobin with endothelium-dependent responses. Circulation 88,2111-2116.
30. Rotterdam ESHRE/ARSM-sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81,19-25.
31. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G and Baron AD (1996) Obesity/insulin resistance is associated with endothelial dysfunction. J Clin Invest 97,2601-2610.
32. Talbott E, Guzick D, Clerici A, Berga S, Detre K, Weimer K and Kuller L (1995) Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol 15,821-826.
33. Talbott EO, Guzick DS, Sutton-Tyrrell K, McHugh-Pemu KP, Zborowski JV, Remsberg KE and Kuller LH (2000) Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle aged women. Arterioscler Thromb Vasc Biol 20,2414-2421.
34. Teoh H, Quan A and Man RY (2000) Acute impairment of relaxation by low levels of testosterone in porcine coronary arteries. Cardiovasc Res 45,1010-1018.
35. Walmsley D and Wiles PG (1990) Assessment of the neurogenic flare response as a measure of nociceptor C fibre function. J Med Engng Technol 14,194-196.
36. Wild RA, Painter PC, Coulson PB, Carruth KB and Ranney GB (1985) Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab 61,946-951.
37. Wild RA, Grubb B, Hartz A, Van Nort JJ, Bachman W and Bartholomew M (1990) Clinical signs of androgen excess as risk factors for coronary artery disease. Fertil Steril 54,255-259.